Ignace B. Vergote, MD, PhD
Ignace B. Vergote, MD, PhD
Professor
University Hospital Leuven
Dept. of OB/GYN
Gasthuisberg
Leuven
Belgium
3000
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)
13
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy